P

harmacy benefit managers are finding themselves in the spotlight more than they used to — and their top lobbyist doesn’t mind.

PBMs and the lobbyists who advocate for them, unsurprisingly, see things differently from Congressman Doug Collins of Georgia, a Republican who last week excoriated PBMs in an interview with STAT. STAT also spoke with Mark Merritt, the CEO of the Pharmaceutical Care Management Organization, about how PBMs view their work.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.

X